TB-500 is a fragment related to Thymosin Beta-4 studied for recovery and flexibility. It is researched most often for Muscle & joint recovery, Flexibility, Wound healing and Cardiac tissue studies. Preclinical research; parent protein (TB4) studied in some human trials. This guide walks through what TB-500 is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is TB-500?
TB-500 is a synthetic version of a region of the naturally occurring protein Thymosin Beta-4, which plays a role in cell migration and blood vessel formation. It is commonly researched alongside BPC-157 for recovery-related outcomes.
Also known as: Thymosin Beta-4 fragment, TB4.
How does TB-500 work?
TB-500 corresponds to an active region of Thymosin Beta-4, a naturally occurring protein that regulates actin, a protein central to cell structure and movement. By influencing cell migration and blood-vessel formation, TB-500 is studied for its potential role in wound healing, flexibility, and muscle and joint recovery.
What is TB-500 researched for?
In the research and community discussion, TB-500 comes up most often in connection with Muscle & joint recovery, Flexibility, Wound healing and Cardiac tissue studies. Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Muscle & joint recovery
- Flexibility
- Wound healing
- Cardiac tissue studies
What does the research actually show?
Preclinical research; parent protein (TB4) studied in some human trials. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting TB-500 as a guaranteed treatment is getting ahead of the evidence.
What is TB-500 typically stacked with?
In the literature and community discussion, TB-500 is most often combined with BPC-157, based on complementary mechanisms. Selpho never provides dosing or protocols — combinations should only be considered with a licensed professional, since interactions and individual context matter.
Safety and considerations
Primarily studied in animal models. Human data on the TB-500 fragment specifically is limited. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about TB-500
To go deeper, see the TB-500 library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where TB-500 might fit your goals.
Frequently asked questions
Recovery-related outcomes: muscle and joint repair, flexibility, wound healing, and some cardiac-tissue studies. Much of the evidence is preclinical.
TB-500 is a synthetic fragment representing an active portion of the full Thymosin Beta-4 protein. Human data specifically on the TB-500 fragment is limited.
Its safety in humans is not established — most research is in animal models. It is not an approved therapy for these uses.
Not sure if TB-500 fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.